Diamine compounds for phosphorescent diazaborole metal complexes and electroluminescent devices

US9859504B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9859504-B2
Application numberUS-201514673232-A
CountryUS
Kind codeB2
Filing dateMar 30, 2015
Priority dateMar 31, 2014
Publication dateJan 2, 2018
Grant dateJan 2, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure generally relates to diamine compounds, which may be used as precursors in preparing diazaborole compounds and phosphorescent diazaborole metal complexes. The present disclosure also relates to diazaborole compounds, diazaborole metal complexes, and electroluminescent emission materials and electronic devices thereof. The present disclosure further relates to processes for preparing the diamine compounds and diazaborole metal complexes.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of Formula 1 or Formula 2: wherein R 1 is selected from C 1-20 alkyl, C 2-20 alkenyl, C 2-20 alkynyl, and a 5 or 6 membered aryl or heteroaryl, each of which is optionally substituted with one or more substituents each independently selected from halo, CN, NO 2 , C(O)R 2 , OR 2 , OS(O) 2 R 2 , NR 2 R 3 , SR 2 , aryl and heteroaryl; wherein R 2 and R 3 are each independently selected from hydrogen and C 1-6 alkyl; Q is an optionally substituted, optionally fused 5 or 6 membered heterocyclic ring, wherein the dashed circle indicates the optional location of up to two optional double bonds in the ring; and Q 1 , Q 2 and Q 3 , are each independently selected from CR 4 or N; wherein at least one of Q 1 , Q 2 and Q 3 is N; and each R 4 is independently selected from hydrogen, halo, CN, NO 2 , C(O)R 2 , OR 2 , OS(O) 2 R 2 , NR 2 R 3 , SR 2 , optionally substituted C 1-20 alkyl, optionally substituted C 2-20 alkenyl, optionally substituted C 2-20 alkynyl, and optionally substituted 5 or 6 membered aryl or heteroaryl, and optionally two R 4 substituents from adjacent ring atoms are joined together to form an optionally substituted 5 or 6 membered aryl or heteroaryl ring; wherein R 2 and R 3 are defined as above; Q 4 , Q 5 and Q 6 , are each independently selected from N, S, O, CR 4 and NR 5 , wherein at least one of Q 4 , Q 5 and Q 6 is selected from N, S, O and NR 5 ; wherein R 4 is defined as above and R 5 is defined according to R 1 above; with the proviso that when T is present then Q 4 is selected from C-T and N-T, and when T is absent Q is not a furo[2,3-C]pyridine group; T is a tether group between rings Q and A of 1 to 3 atoms in length linked together in a linear chain, wherein the dashed lines between Q 4 atom and A ring indicates T is an optional group, and wherein T is selected from C, N, O, S, Si and B, each of which is optionally substituted with one or more substituents independently selected from hydrogen, halo, CN, NO 2 , ═O, C(O)R 2 , OR 2 , OS(O) 2 R 2 , NR 2 R 3 , SR 2 , optionally substituted C 1-10 alkyl, optionally substituted C 2-10 alkenyl, optionally substituted C 2-10 alkynyl and optionally substituted 5 or 6 membered aryl or heteroaryl, and optionally fused with a 3-6 membered carbocycle or heterocycle; and wherein R 2 and R 3 are each independently defined as above, A is a monocyclic or bicyclic 5 or 6 membered heterocyclic ring containing a donor atom D and a ring atom A 1 , and optionally having 1 or 2 additional ring heteroatoms selected from O, S and N, wherein the heterocyclic ring is optionally substituted with 1 to 3 substituents independently selected from hydrogen, halo, CN, NO 2 , C(O)R 2 , OR 2 , OS(O) 2 R 2 , NR 2 R 3 , SR 2 , optionally substituted C 1-20 alkyl, optionally substituted C 2-20 alkenyl, optionally substituted C 2-20 alkynyl, and optionally substituted 5 or 6 membered aryl or heteroaryl; wherein R 2 and R 3 are each independently defined as above; A 1 is selected from C, O, S, N, CR 8 , C(R 8 ) 2 and NR 9 ; wherein each R 8 is independently selected from hydrogen, halo, CN, NO 2 , C(O)R 2 , OR 2 , OS(O) 2 R 2 , NR 2 R 3 , SR 2 , optionally substituted C 1-20 alkyl, optionally substituted C 2-20 alkenyl, optionally substituted C 2-20 alkynyl, optionally substituted 5 or 6 membered aryl or heteroaryl; wherein R 9 is selected from hydrogen, C 1-20 alkyl, C 2-20 alkenyl, C 2-20 alkynyl, and a 5 or 6 membered aryl or heteroaryl, each of which can be optionally substituted with one or more substituents independently selected from halo, CN, NO 2 , C(O)R 2 , OR 2 , OS(O) 2 R 2 , NR 2 R 3 , SR 2 , aryl and heteroaryl; and wherein R 2 and R 3 are defined as above; and D is a donor atom selected from N, O, S, P, Se and Te. 2. The compound of claim 1 , wherein R 1 is selected from optionally substituted C 1-10 alkyl and optionally substituted monocyclic 5 or 6 membered aryl or heteroaryl. 3. The compound of claim 1 , wherein the compound is of Formula 1, wherein Q 1 , Q 2 and Q 3 are each independently selected from CR 4 or N; and wherein at least one of Q 1 , Q 2 and Q 3 is N. 4. The compound of claim 1 , wherein the compound is of Formula 2, wherein when T is present, Q 4 is selected from C-T and N-T. 5. The compound of claim 1 , wherein Q 4 , Q 5 and Q 6 , are each independently selected from N, S and CR 4 , and at least one of Q 4 , Q 5 and Q 6 is selected from N and S. 6. The compound of claim 5 , wherein Q 5 is S and Q 4 and Q 6 are CR 4 . 7. The compound of claim 1 , which is selected from a compound of Formula 2, wherein when T is absent, Q 4 , Q 5 and Q 6 , are each independently selected from N, S, CR 4 and NR 5 , wherein at least one of Q 4 , Q 5 and Q 6 is selected from N, S and NR 5 . 8. The compound of claim 1 , wherein T is a tether group provided by a linear chain of 1 to 3 atoms in length independently selected from —N(R 7 )—, —N(R 7 )—C(═O)—, —O—, —O—C(═O)—, —C(═O)—, —S—, —S(═O)—, —S(═O) 2 —, C 1-3 alkyl and C 2-3 alkenyl; wherein the C 1-3 alkyl and C 2-3 alkenyl are each optionally interrupted by a group selected from —N(R 7 )—, —N(R 7 )—C(═O)—, —O—, —O—C(═O)—, —C(═O)—, —S—, —S(═O)— and S(═O) 2 , and optionally substituted with one or more substituents independently selected from halo, CN, NO 2 , C(O)R 2 , OR 2 , OS(O) 2 R 2 , NR 2 R 3 , SR 2 , C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 1-10 alkylhalo, C 2-10 alkenylhalo and C 2-10 alkynylhalo, and optionally fused with a 3-6 membered carbocycle or heterocycle; and wherein R 7 is selected from hydrogen and C 1-10 alkyl. 9. The compound of claim 8 , wherein T is the optionally substituted, optionally fused C 1-3 alkyl. 10. The compound of claim 1 , wherein A is an optionally substituted monocyclic or bicyclic 5 or 6 membered heteroaryl ring. 11. The compound of claim 1 , wherein D is N. 12. The compound of claim 1 , wherein A is an optionally substituted pyridine group. 13. A compound of Formula 3 or Formula 4: wherein R 1 is selected from C 1-20 alkyl, C 2-20 alkenyl, C 2-20 alkynyl, and a 5 or 6 membered aryl or heteroaryl, each of which is optionally substituted with one or more substituents each independently selected from halo, CN, NO 2 , C(O)R 2 , OR 2 , OS(O) 2 R 2 , NR 2 R 3 , SR 2 , aryl and heteroaryl; wherein R 2 and R 3 are each independently selected from hydrogen and C 1-6 alkyl; Q is an optionally substituted, optionally fused 5 or 6 membered heterocyclic ring, wherein the dashed circle indicates the optional location of up to two optional double bonds in the ring; and Q 1 , Q 2 and Q 3 , are each independently selected from CR 4 or N; wherein at least one of Q 1 , Q 2 and Q 3 is N; and each R 4 is independently selected from hydrogen, halo, CN, NO 2 , C(O)R 2 , OR 2 , OS(O) 2 R 2 , NR 2 R 3 , SR 2 , optionally substituted C 1-20 alkyl, optionally substituted C 2-20 alkenyl, optionally substituted C 2-20 alkynyl, and optionally substituted 5 or 6 membered aryl or heteroaryl, and optionally two R 4 substituents from adjacent ring atoms are joined together to form an optionally substituted 5 or 6 membered aryl or heteroaryl ring; wherein R 2 and R 3 are defined as above; Q 4 , Q 5 and Q 6 , are each independently selected from N, S, O, CR 4 and NR 5 , wherein at least one of Q 4 , Q 5 and Q 6 is selected from N, S, O and NR 5 ; wherein R 4

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9859504B2 cover?
The present disclosure generally relates to diamine compounds, which may be used as precursors in preparing diazaborole compounds and phosphorescent diazaborole metal complexes. The present disclosure also relates to diazaborole compounds, diazaborole metal complexes, and electroluminescent emission materials and electronic devices thereof. The present disclosure further relates to processes fo…
Who is the assignee on this patent?
Commw Scient Ind Res Org
What technology area does this patent fall under?
Primary CPC classification H01L51/0068. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).